45
Quince Therapeutics, Inc. raises $7.4M under Reg D
Company raise · Pre-first close · Offering $7.4M · SOUTH SAN FRANCISCO, CA · filed 2026-06-11
Placement agent engagedBusiness combination
60
Quince Therapeutics, Inc. raises $114.7M under Reg D
Company raise · Raising · SOUTH SAN FRANCISCO, CA · Form D filed 2026-06-11
$50M+ raisePlacement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Dirk Thye | Executive Officer, Director |
| June Bray | Director |
| Brendan Hannah | Executive Officer |
| Brigette Roberts | Executive Officer, Director |
| Charles Ryan | Executive Officer |
| Christopher Senner | Director |
| David Lamond | Director |
Signed by Dirk Thye, Chief Executive Officer.
Placement agents / sales compensation: LifeSci Capital
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
57
Quince Therapeutics, Inc. raises $11.5M under Reg D
Company raise · Raising · Offering $21.9M · Sold $11.5M · SOUTH SAN FRANCISCO, CA · filed 2025-07-01
Placement agent engaged